KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Cost of Revenue (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Cost of Revenue data on record, last reported at $50.4 million in Q4 2025.

  • For Q4 2025, Cost of Revenue rose 202.01% year-over-year to $50.4 million; the TTM value through Dec 2025 reached $377.3 million, down 59.61%, while the annual FY2025 figure was $377.3 million, 1.33% up from the prior year.
  • Cost of Revenue reached $50.4 million in Q4 2025 per CRL's latest filing, down from $77.6 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $672.4 million in Q2 2024 and bottomed at -$1.5 billion in Q4 2023.
  • Average Cost of Revenue over 5 years is $186.0 million, with a median of $171.3 million recorded in 2024.
  • Peak YoY movement for Cost of Revenue: tumbled 243.41% in 2022, then skyrocketed 604.78% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $468.1 million in 2021, then crashed by 243.41% to -$671.3 million in 2022, then plummeted by 118.6% to -$1.5 billion in 2023, then skyrocketed by 96.63% to -$49.4 million in 2024, then surged by 202.01% to $50.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $50.4 million in Q4 2025, $77.6 million in Q3 2025, and $110.0 million in Q2 2025.